腹腔镜胃次全切除术治疗进展期胃癌的技术与结局
本研究纳入253例接受根治性腹腔镜胃切除术的进展期胃癌患者,其中27例行腹腔镜胃次全切除术(LsTG)。结果显示LsTG在并发症和术后体重丢失方面与腹腔镜远端胃切除术(LcDG)无差异,且优于腹腔镜全胃切除术(LTG)。LsTG治疗进展期胃癌在手术和营养方面可能比LTG更安全。
要点
- LsTG适用于上三分之一胃肿瘤且希望避免全胃切除的患者。
- LsTG的并发症和体重丢失与LcDG无差异,且优于LTG。
- 进展期胃癌行腹腔镜胃切除术在手术和肿瘤学上是可行且安全的。
核心结论
- 进展期胃癌行腹腔镜胃切除术在手术和肿瘤学上是可行且安全的。
- LsTG治疗进展期胃癌在手术和术后营养方面可能比LTG更安全。
研究设计与样本
- 回顾性纳入2008至2012年间816例连续胃癌患者中253例接受根治性腹腔镜胃切除术的进展期胃癌患者。
- LsTG适用于上三分之一胃肿瘤、希望避免全胃切除、距食管胃结合部<4 cm且近端切缘2 cm冰冻切片阴性者。
- 主要评估手术结局和术后营养状态。
主要发现
- 253例患者中,并发症(Clavien-Dindo分级≥III级)发生率为17.0%(43例)。
- 3年总生存率和3年无复发生存率分别为80.2%和73.5%。
- LcDG、LsTG和LTG分别施行于121例、27例和105例患者。
- 并发症与LTG强烈相关(P=0.001)。
- LTG术后体重丢失显著大于LcDG或LsTG(P<0.001),LcDG与LsTG组间并发症和体重丢失无差异。
临床怎么用
- 对于上三分之一胃肿瘤且希望避免全胃切除的进展期胃癌患者,可考虑行LsTG。
- LsTG在并发症和术后体重丢失方面可能优于LTG。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Higher morbidity in total gastrectomy than in distal gastrectomy has been reported, but laparoscopic subtotal gastrectomy (LsTG) has been reported to be safe and feasible in early gastric cancer (GC). We determined the surgical, nutritional and oncological outcomes of LsTG for advanced gastric cancer (AGC). METHODS: Of the 816 consecutive patients with GC who underwent radical gastrectomy at our institution between 2008 and 2012, 253 who underwent curative laparoscopic gastrectomy (LG) for AGC were enrolled. LsTG was indicated for patients with upper stomach third tumors, who hoped to avoid total gastrectomy, <4 cm to the esophagogastric junction and a 2-cm proximal margin with cut end negative in frozen section, whereas laparoscopic conventional distal gastrectomy (LcDG) and laparoscopic total gastrectomy (LTG) were performed otherwise. Surgical outcomes and postoperative nutritional status were primarily assessed. RESULTS: Of 253 patients, the morbidity (Clavien-Dindo classification grade ≥ III) was 17.0% (43 patients). The 3-year overall survival and 3-year recurrence-free survival rates were 80.2 and 73.5%, respectively. LcDG, LsTG and LTG were performed in 121, 27 and 105 patients, individually. Morbidity was strongly associated with LTG (P = 0.001). Postoperative loss of body weight was significantly greater after LTG in comparison with LcDG or LsTG (P < 0.001). No difference in morbidity and postoperative loss of body weight were observed between LcDG and LsTG group. CONCLUSIONS: LG for AGC was feasible and safe surgically and oncologically. LsTG for AGC may be safer than LTG from surgical and postoperative nutritional point of view.
引用
- Nakauchi M, Suda K, Nakamura K, et al. Laparoscopic subtotal gastrectomy for advanced gastric cancer: technical aspects and surgical, nutritional and oncological outcomes. Surg Endosc. 2017. PMID: 28389797. doi:10.1007/s00464-017-5526-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。